Analysts at UBS Investment Research took a look at MetLife during Investor Day and concluded that the company has a "great outlook, but over time."
Although MetLife's global outlook looks strong, its ROE targets may take longer to come to fruition than investors would like. MetLife is currently targeting a 12-14 percent op ROE by 2016, up from 10.3 percent in 2011, despite headwinds.
In order to achieve 2016's ROE targets, MetLife hopes to employ a mix shift toward protection products with stable returns, $1 billion of efficiency gains and growth in high return emerging markets.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
